Clinical Trial Update: Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection [Phase 1, Phase 2]

View source ↗

Summary

A dual anti-HIV gene transfer construct was studied in Phase 1/2 safety trials for HIV-1 infection; the study is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Dual anti-HIV gene transfer construct

Snippet

Sponsor: Calimmune, Inc. | Conditions: Human Immunodeficiency Virus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-06